Gruss Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Gruss Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-88,250	Closed	-$2.56M	–	58
2016 Q1	$2.56M	Hold	88,250	–	–	0.08%	38
2015 Q4	$3.28M	Hold	88,250	–	–	0.11%	61
2015 Q3	$4.3M	Hold	88,250	–	–	0.14%	51
2015 Q2	$6.09M	Sell	88,250 -43,750	-33%	-$2.03M	0.22%	42
2015 Q1	$4.72M	Buy	132,000 +12,000	+10%	+$355K	0.19%	41
2014 Q4	$1.52M	Buy	120,000 +12,500	+12%	+$182K	0.04%	80
2014 Q3	$1.65M	Buy	107,500 +104,180	+3,138%	+$2.19M	0.07%	59
2014 Q2	$90K	Buy	+3,320	New	+$81.9K	﹤0.01%	76

Other funds holding ANTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gruss Capital Management's ANTH Position: Q2 2016 in Review

Gruss Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2016, closing a stake of 88,250 shares — an estimated $2.56M sold.

Gruss Capital Management first reported a position in ANTH in Q2 2014 and held it in 8 quarters. The position peaked at $6.09M in Q2 2015. 74 funds tracked by Wall St. Rank hold ANTH as of Q2 2016.

Gruss Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Gruss Capital Management sold 88,250 Anthera Pharmaceuticals, Inc. shares in Q2 2016, an estimated $2.56M.
Gruss Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2014 and held it in 8 quarters.
Gruss Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $6.09M in Q2 2015.
74 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2016.

Based on Gruss Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.